QQ客服 官方微博 反馈留言

	Ezrin promotes breast cancer progression by modulating AKT signals.
	Nan Li; Jienan Kong; Zhenhua Lin; Yang Yang; Tiefeng Jin; Ming Xu; Jie Sun; Liyan Chen
刊名	British journal of cancer
	2019
ISSN号	1532-1827
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4743594
专题	湖南大学
作者单位	Department of Pathology and Cancer Research Center, Yanbian University Medical College, Yanji, 133002, China. Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China. Key laboratory of the Science and Technology Department of Jilin Province, Yanji, 133002, China. Department of Biochemistry and molecular biology, Yanbian University Medical College, Yanji, 133002, China. lychen@ybu.edu.cn. Key laboratory of the Science and Technology Department of Jilin Province, Yanji, 133002, China. lychen@ybu.edu.cn.
推荐引用方式 GB/T 7714	Nan Li,Jienan Kong,Zhenhua Lin,et al. Ezrin promotes breast cancer progression by modulating AKT signals.[J]. British journal of cancer,2019.
APA	Nan Li.,Jienan Kong.,Zhenhua Lin.,Yang Yang.,Tiefeng Jin.,...&Liyan Chen.(2019).Ezrin promotes breast cancer progression by modulating AKT signals..British journal of cancer.
MLA	Nan Li,et al."Ezrin promotes breast cancer progression by modulating AKT signals.".British journal of cancer (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。